Benjamin Richard Brown, MD
Family Practice · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brown’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G77821 · Current
Licensed to practise in California · since 1993 · expires 2027-07-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$17,280
Medicare paid this office $17,280 for 196 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 125 | $9,812 | $76 |
| Return visit (30+ min) | 32 | $3,551 | $108 |
| Long return visit (40+ min) | 11 | $1,382 | $126 |
| New patient visit (30+ min) | 12 | $750 | $63 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
196 Original Medicare patients in 2024. Average age 75 · Under 65 7% · 85 and older 17% · Women 66% · Also on Medicaid 17% · Health risk score 1.32. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 59% · Coronary heart disease 25% · Diabetes 19% · Cancer 18% · Chronic kidney disease 17% · Depression 17% · Atrial fibrillation 16% · Heart failure 12% · COPD 12% · Stroke 7% · Dementia 6%.
The office billed $54,025, Medicare allowed $24,686 and paid $17,280; for 209 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 196 | 209 | 75 | 1.32 | $54,025 | $17,280 |
| 2023 | 214 | 234 | 75 | 1.28 | $56,950 | $19,062 |
| 2022 | 214 | 239 | 75 | 1.25 | $57,393 | $19,481 |
| 2021 | 74 | 76 | 75 | 1.22 | $23,190 | $6,752 |
| 2020 | 18 | 18 | 77 | 1.18 | $4,166 | $937 |
| 2014 | 16 | 16 | 68 | 1.77 | $7,437 | $1,964 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 178 | $15,749 | $82 |
| Return visit (30+ min) | 13 | $1,332 | $102 |
2022: 3 services
| Return visit (30+ min) | 161 | $13,682 | $82 |
| Long return visit (40+ min) | 21 | $2,532 | $121 |
| New patient visit (30+ min) | 18 | $1,111 | $62 |
2021: 2 services
| Return visit (30+ min) | 40 | $3,379 | $84 |
| Long return visit (40+ min) | 15 | $1,925 | $128 |
2020: 1 service
| Short return visit (20+ min) | 14 | $635 | $45 |
Medicaid work
$133,389 in 2022
Medicaid paid $133,389 for 2,051 billed services this clinician did in 2022, up to 278 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 637 | $130,612 |
| Short return visit (20+ min) | 1,385 | $2,589 |
| Return visit (30+ min) | 29 | $188 |
| 2022 | 2,051 | 3 | 278 | $133,389 |
| 2021 | 642 | 3 | 109 | $55,501 |
| 2020 | 1,410 | 3 | 60 | $119,570 |
| 2019 | 1,297 | 6 | 86 | $79,082 |
| 2018 | 661 | 2 | 149 | $103,289 |
See the largest Medicaid services in earlier years
2021
| Clinic visit/encounter, all-inclusive | 262 | $55,165 |
| Short return visit (20+ min) | 366 | $336 |
| Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 14 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 583 | $118,829 |
| Short return visit (20+ min) | 759 | $741 |
| Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 68 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 484 | $77,896 |
| Short return visit (20+ min) | 594 | $728 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 51 | $284 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 25 | $173 |
| EMERGENCY DEPT VISIT LOW MDM | 52 | $0 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 91 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 589 | $103,169 |
| Short return visit (20+ min) | 72 | $120 |
Drugs they prescribed that Part D paid
$4,185
Pharmacies billed $4,185 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
105 generic and 35 brand-name prescriptions · $4,185 in drug cost · 21 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluticasone Propionate | 16 | $274 | $8 |
| Paxlovid | 13 | $0 | $0 |
Year by year
| 2024 | 140 | 81 | None | 25% | $4,185 |
| 2023 | 154 | 93 | 0% (0) | None | $8,976 |
| 2022 | 137 | 85 | None | 20% | $13,098 |
| 2021 | 454 | 58 | 4% (19) | 14% | $37,632 |
| 2020 | 730 | 64 | 8% (58) | 13% | $64,420 |
| 2019 | 748 | 50 | 10% (73) | 12% | $58,772 |
| 2018 | 984 | 58 | 10% (100) | 15% | $76,849 |
| 2017 | 1,067 | 74 | 11% (114) | 16% | $77,122 |
| 2016 | 1,137 | 82 | 11% (130) | 16% | $69,247 |
| 2015 | 1,238 | 66 | 12% (143) | 16% | $69,291 |
| 2014 | 1,534 | 100 | 11% (170) | 20% | $101,232 |
| 2013 | 2,202 | 120 | 9% (204) | 21% | $126,679 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 11 drugs
| Atorvastatin | 15 | $507 | $34 |
| Doxycycline Hyclate | 13 | $437 | $34 |
| Levothyroxine | 17 | $437 | $26 |
| Bupropion Hcl Sr | 18 | $328 | $18 |
| Terazosin | 11 | $223 | $20 |
| Lisinopril | 16 | $102 | $6 |
| Trazodone | 15 | $86 | $6 |
| Spironolactone | 11 | $75 | $7 |
| Amlodipine Besylate | 12 | $68 | $6 |
| Simvastatin | 11 | $54 | $5 |
| Citalopram Hbr | 11 | $21 | $2 |
2020: 30 drugs
| Creon | 14 | $16,477 | $1,177 |
| Ventolin Hfa | 17 | $1,383 | $81 |
| Hydrocodone-Acetaminophen | 33 | $561 | $17 |
| Triamcinolone Acetonide | 19 | $508 | $27 |
| Levothyroxine | 22 | $409 | $19 |
| Sucralfate | 17 | $399 | $23 |
| Insulin | 13 | $397 | $31 |
| Morphine Sulfate Er | 13 | $378 | $29 |
| Dextroamphetamine-Amphetamine | 11 | $339 | $31 |
| Duloxetine | 11 | $312 | $28 |
| Gabapentin | 13 | $309 | $24 |
| Pravastatin | 12 | $170 | $14 |
| Hydrocortisone | 13 | $145 | $11 |
| Bupropion Hcl Sr | 14 | $139 | $10 |
| Atorvastatin | 14 | $138 | $10 |
| Amlodipine Besylate | 19 | $114 | $6 |
| Doxycycline Hyclate | 14 | $111 | $8 |
| Diazepam | 14 | $108 | $8 |
| Terazosin | 12 | $107 | $9 |
| Simvastatin | 24 | $104 | $4 |
| Trazodone | 24 | $88 | $4 |
| Omeprazole | 11 | $85 | $8 |
| Mirtazapine | 12 | $70 | $6 |
| Clonazepam | 13 | $67 | $5 |
| Lithium Carbonate | 11 | $62 | $6 |
| Metformin | 12 | $60 | $5 |
| Lisinopril | 16 | $51 | $3 |
| Lorazepam | 14 | $44 | $3 |
| Citalopram Hbr | 12 | $29 | $2 |
| Spironolactone | 11 | $27 | $2 |
2019: 29 drugs
| Ventolin Hfa | 11 | $739 | $67 |
| Triamcinolone Acetonide | 39 | $575 | $15 |
| Insulin | 18 | $541 | $30 |
| Enalapril Maleate | 13 | $523 | $40 |
| Hydrocodone-Acetaminophen | 37 | $462 | $12 |
| Levothyroxine | 20 | $452 | $23 |
| Morphine Sulfate Er | 14 | $415 | $30 |
| Esomeprazole Magnesium | 13 | $352 | $27 |
| Pravastatin | 11 | $348 | $32 |
| Bupropion Hcl Sr | 16 | $342 | $21 |
| Dextroamphetamine-Amphetamine | 11 | $341 | $31 |
| Tamsulosin | 11 | $313 | $28 |
| Gabapentin | 17 | $278 | $16 |
| Diclofenac | 13 | $235 | $18 |
| Sucralfate | 12 | $181 | $15 |
| Mirtazapine | 11 | $144 | $13 |
| Doxycycline Hyclate | 13 | $112 | $9 |
| Lithium Carbonate | 11 | $112 | $10 |
| Ranitidine | 15 | $108 | $7 |
| Diazepam | 12 | $102 | $9 |
| Terazosin | 11 | $97 | $9 |
| Clonazepam | 13 | $90 | $7 |
| Hydrocortisone | 18 | $90 | $5 |
| Amlodipine Besylate | 17 | $81 | $5 |
| Trazodone | 18 | $80 | $4 |
| Simvastatin | 16 | $79 | $5 |
| Carisoprodol | 12 | $52 | $4 |
| Lisinopril | 17 | $52 | $3 |
| Lorazepam | 13 | $47 | $4 |
2018: 37 drugs
| Novolin N | 13 | $11,786 | $907 |
| Promethegan | 11 | $4,278 | $389 |
| Ventolin Hfa | 20 | $1,331 | $67 |
| Duloxetine | 20 | $1,221 | $61 |
| Hydrocodone-Acetaminophen | 54 | $702 | $13 |
| Enalapril Maleate | 17 | $678 | $40 |
| Triamcinolone Acetonide | 33 | $657 | $20 |
| Levothyroxine | 19 | $599 | $32 |
| Tamsulosin | 14 | $501 | $36 |
| Morphine Sulfate Er | 12 | $428 | $36 |
| Gabapentin | 28 | $343 | $12 |
| Insulin | 13 | $321 | $25 |
| Polyethylene Glycol 3350 | 24 | $312 | $13 |
| Atorvastatin | 16 | $310 | $19 |
| Methadone | 11 | $309 | $28 |
| Pravastatin | 18 | $266 | $15 |
| Bupropion Hcl Sr | 13 | $230 | $18 |
| Diazepam | 21 | $197 | $9 |
| Lithium Carbonate | 12 | $192 | $16 |
| Finasteride | 11 | $172 | $16 |
| Phenytoin Sodium Extended | 12 | $170 | $14 |
| Mirtazapine | 12 | $166 | $14 |
| Doxycycline Hyclate | 14 | $132 | $9 |
| Metformin | 26 | $124 | $5 |
| Amlodipine Besylate | 39 | $121 | $3 |
| Simvastatin | 31 | $112 | $4 |
| Clonazepam | 12 | $110 | $9 |
| Omeprazole | 14 | $103 | $7 |
| Zolpidem | 15 | $89 | $6 |
| Metformin Hcl Er | 11 | $83 | $8 |
| Carisoprodol | 13 | $83 | $6 |
| Hydrocortisone | 11 | $55 | $5 |
| Lorazepam | 11 | $52 | $5 |
| Furosemide | 15 | $50 | $3 |
| Metoprolol | 20 | $48 | $2 |
| Lisinopril | 14 | $40 | $3 |
| Cyclobenzaprine | 11 | $9 | $1 |
2017: 45 drugs
| Novolin N | 16 | $10,860 | $679 |
| Novolin R | 12 | $4,823 | $402 |
| Prempro | 11 | $1,980 | $180 |
| Ventolin Hfa | 21 | $1,175 | $56 |
| Duloxetine | 11 | $1,133 | $103 |
| Ultra-Fine Nano Pen Needle | 16 | $1,075 | $67 |
| Enalapril Maleate | 17 | $867 | $51 |
| Tamsulosin | 21 | $857 | $41 |
| Methadone | 16 | $697 | $44 |
| Hydrocodone-Acetaminophen | 54 | $528 | $10 |
| Aripiprazole | 11 | $486 | $44 |
| Triamcinolone Acetonide | 26 | $484 | $19 |
| Morphine Sulfate Er | 12 | $444 | $37 |
| Levothyroxine | 13 | $439 | $34 |
| Phenytoin Sodium Extended | 12 | $369 | $31 |
| Atorvastatin | 18 | $349 | $19 |
| Dextroamphetamine-Amphetamine | 11 | $324 | $29 |
| Bupropion Hcl Sr | 12 | $308 | $26 |
| Polyethylene Glycol 3350 | 13 | $300 | $23 |
| Insulin | 12 | $297 | $25 |
| Fluticasone Propionate | 16 | $283 | $18 |
| Metformin | 41 | $279 | $7 |
| Doxycycline Hyclate | 13 | $248 | $19 |
| Gabapentin | 18 | $223 | $12 |
| Amlodipine Besylate | 34 | $199 | $6 |
| Mirtazapine | 15 | $178 | $12 |
| Lithium Carbonate | 11 | $175 | $16 |
| Omeprazole | 18 | $151 | $8 |
| Nortriptyline | 14 | $139 | $10 |
| Carisoprodol | 20 | $125 | $6 |
| Trazodone | 11 | $115 | $10 |
| Simvastatin | 31 | $97 | $3 |
| Ibu | 15 | $96 | $6 |
| Zolpidem | 17 | $93 | $5 |
| Klor-Con 8 | 12 | $92 | $8 |
| Diazepam | 18 | $89 | $5 |
| Furosemide | 18 | $87 | $5 |
| Clonazepam | 12 | $87 | $7 |
| Metformin Hcl Er | 11 | $80 | $7 |
| Lisinopril | 25 | $72 | $3 |
| Clonidine | 11 | $65 | $6 |
| Lorazepam | 13 | $60 | $5 |
| Hydrocortisone | 12 | $60 | $5 |
| Tramadol | 15 | $54 | $4 |
| Ranitidine | 13 | $43 | $3 |
2016: 40 drugs
| Novolin N | 14 | $7,697 | $550 |
| Nexium | 11 | $2,818 | $256 |
| Enalapril Maleate | 19 | $1,000 | $53 |
| Amitriptyline | 15 | $898 | $60 |
| Hydrocodone-Acetaminophen | 56 | $848 | $15 |
| Ventolin Hfa | 14 | $790 | $56 |
| Bd Ultra-Fine Pen Needle | 11 | $785 | $71 |
| Levothyroxine | 23 | $667 | $29 |
| Proair Hfa | 12 | $643 | $54 |
| Liothyronine | 12 | $628 | $52 |
| Methadone | 16 | $566 | $35 |
| Oxycodone | 12 | $541 | $45 |
| Insulin | 26 | $532 | $20 |
| Phenytoin Sodium Extended | 12 | $493 | $41 |
| Morphine Sulfate Er | 12 | $492 | $41 |
| Doxycycline Hyclate | 13 | $488 | $38 |
| Triamcinolone Acetonide | 27 | $467 | $17 |
| Tamsulosin | 14 | $387 | $28 |
| Metformin | 44 | $375 | $9 |
| Bupropion Hcl Sr | 23 | $342 | $15 |
| Gabapentin | 21 | $305 | $15 |
| Atorvastatin | 15 | $285 | $19 |
| Trazodone | 26 | $242 | $9 |
| Mirtazapine | 15 | $204 | $14 |
| Omeprazole | 34 | $195 | $6 |
| Lithium Carbonate | 12 | $179 | $15 |
| Dicyclomine | 17 | $169 | $10 |
| Carisoprodol | 25 | $141 | $6 |
| Promethazine | 13 | $127 | $10 |
| Amlodipine Besylate | 36 | $124 | $3 |
| Lamotrigine | 13 | $110 | $8 |
| Simvastatin | 23 | $105 | $5 |
| Ibuprofen | 13 | $89 | $7 |
| Lisinopril | 24 | $69 | $3 |
| Citalopram Hbr | 14 | $62 | $4 |
| Sertraline | 12 | $55 | $5 |
| Diazepam | 30 | $55 | $2 |
| Lorazepam | 15 | $50 | $3 |
| Zolpidem | 15 | $42 | $3 |
| Furosemide | 12 | $34 | $3 |
2015: 39 drugs
| Novolin N | 22 | $7,817 | $355 |
| Atrovent Hfa | 20 | $5,233 | $262 |
| Prempro | 13 | $1,752 | $135 |
| Methadone Intensol | 12 | $1,147 | $96 |
| Morphine Sulfate Er | 26 | $1,137 | $44 |
| Hydrocodone-Acetaminophen | 53 | $1,062 | $20 |
| Levothyroxine | 50 | $1,036 | $21 |
| Proair Hfa | 17 | $966 | $57 |
| Enalapril Maleate | 21 | $899 | $43 |
| Nitrofurantoin Mono-Macro | 11 | $797 | $72 |
| Methadone | 12 | $641 | $53 |
| Oxycodone | 11 | $564 | $51 |
| Triamcinolone Acetonide | 30 | $515 | $17 |
| Insulin | 24 | $494 | $21 |
| Gabapentin | 15 | $364 | $24 |
| Simvastatin | 65 | $299 | $5 |
| Pravastatin | 12 | $296 | $25 |
| Promethazine | 24 | $289 | $12 |
| Omeprazole | 37 | $245 | $7 |
| Bupropion Hcl Sr | 14 | $235 | $17 |
| Atorvastatin | 14 | $187 | $13 |
| Mirtazapine | 12 | $153 | $13 |
| Trazodone | 25 | $152 | $6 |
| Fluticasone Propionate | 15 | $149 | $10 |
| Dicyclomine | 18 | $142 | $8 |
| Metformin | 20 | $114 | $6 |
| Carisoprodol | 18 | $109 | $6 |
| Amlodipine Besylate | 37 | $108 | $3 |
| Lithium Carbonate | 11 | $100 | $9 |
| Diazepam | 34 | $99 | $3 |
| Sertraline | 17 | $96 | $6 |
| Lorazepam | 14 | $73 | $5 |
| Losartan | 17 | $73 | $4 |
| Ibuprofen | 16 | $70 | $4 |
| Atenolol | 16 | $61 | $4 |
| Citalopram Hbr | 12 | $60 | $5 |
| Glipizide | 13 | $46 | $4 |
| Losartan-Hydrochlorothiazide | 11 | $46 | $4 |
| Furosemide | 12 | $12 | $1 |
2014: 58 drugs
| Lantus | 19 | $11,579 | $609 |
| Abilify | 12 | $11,061 | $922 |
| Novolin N | 21 | $5,988 | $285 |
| Advair Diskus | 17 | $4,888 | $288 |
| Levemir | 11 | $3,703 | $337 |
| Nexium | 13 | $3,097 | $238 |
| Atrovent Hfa | 11 | $2,670 | $243 |
| Qvar | 17 | $2,497 | $147 |
| Olanzapine | 17 | $1,504 | $88 |
| Prempro | 13 | $1,474 | $113 |
| Hydrocodone-Acetaminophen | 84 | $1,174 | $14 |
| Methadone Intensol | 11 | $1,062 | $97 |
| Proair Hfa | 17 | $984 | $58 |
| Morphine Sulfate Er | 25 | $972 | $39 |
| Xopenex Hfa | 14 | $808 | $58 |
| Nitrofurantoin Mono-Macro | 11 | $803 | $73 |
| Levothyroxine | 41 | $788 | $19 |
| Oxycodone | 13 | $780 | $60 |
| Promethazine | 29 | $779 | $27 |
| Enalapril Maleate | 47 | $587 | $12 |
| Triamcinolone Acetonide | 26 | $474 | $18 |
| Bupropion Hcl Sr | 14 | $462 | $33 |
| Simvastatin | 67 | $454 | $7 |
| Albuterol Sulfate | 11 | $443 | $40 |
| Losartan | 24 | $432 | $18 |
| Metformin | 40 | $417 | $10 |
| Insulin | 17 | $371 | $22 |
| Gabapentin | 15 | $352 | $23 |
| Carisoprodol | 12 | $350 | $29 |
| Divalproex | 12 | $340 | $28 |
| Methadone | 12 | $262 | $22 |
| Terazosin | 27 | $256 | $9 |
| Metformin Hcl Er | 15 | $238 | $16 |
| Trazodone | 35 | $210 | $6 |
| Omeprazole | 29 | $207 | $7 |
| Amlodipine Besylate | 43 | $196 | $5 |
| Mirtazapine | 17 | $194 | $11 |
| Sertraline | 16 | $191 | $12 |
| Potassium Chloride | 17 | $179 | $11 |
| Carvedilol | 13 | $176 | $14 |
| Ranitidine | 18 | $169 | $9 |
| Zolpidem | 21 | $160 | $8 |
| Finasteride | 13 | $133 | $10 |
| Lamotrigine | 11 | $122 | $11 |
| Lithium Carbonate | 12 | $118 | $10 |
| Atenolol | 20 | $115 | $6 |
| Lovastatin | 11 | $114 | $10 |
| Diazepam | 28 | $111 | $4 |
| Lorazepam | 15 | $96 | $6 |
| Dicyclomine | 12 | $89 | $7 |
| Ibuprofen | 15 | $89 | $6 |
| Glipizide | 13 | $79 | $6 |
| Citalopram Hbr | 12 | $78 | $7 |
| Hydrochlorothiazide | 16 | $76 | $5 |
| Metoprolol | 16 | $73 | $5 |
| Furosemide | 20 | $69 | $3 |
| Lisinopril | 12 | $62 | $5 |
| Meloxicam | 11 | $61 | $6 |
2013: 75 drugs
| Abilify | 14 | $12,015 | $858 |
| Cymbalta | 29 | $9,943 | $343 |
| Lantus | 21 | $9,671 | $461 |
| Ziprasidone | 25 | $7,199 | $288 |
| Advair Diskus | 23 | $6,115 | $266 |
| Novolin N | 23 | $5,332 | $232 |
| Pancreaze | 11 | $4,042 | $367 |
| Atrovent Hfa | 12 | $3,104 | $259 |
| Levemir | 14 | $2,966 | $212 |
| Nexium | 13 | $2,843 | $219 |
| Humulin N | 11 | $2,719 | $247 |
| Detrol La | 12 | $2,350 | $196 |
| Proair Hfa | 33 | $1,800 | $55 |
| Zetia | 11 | $1,732 | $157 |
| Morphine Sulfate Er | 36 | $1,483 | $41 |
| Losartan | 47 | $1,356 | $29 |
| Benicar | 12 | $1,294 | $108 |
| Oxycodone | 13 | $1,290 | $99 |
| Prempro | 13 | $1,284 | $99 |
| Hydrocodone-Acetaminophen | 111 | $1,253 | $11 |
| Doxycycline Hyclate | 16 | $1,168 | $73 |
| Metformin | 104 | $1,109 | $11 |
| Olanzapine | 12 | $963 | $80 |
| Liothyronine | 12 | $886 | $74 |
| Methadone | 22 | $793 | $36 |
| Simvastatin | 80 | $759 | $9 |
| Fluticasone Propionate | 26 | $691 | $27 |
| Amphetamine Salt Combo | 13 | $678 | $52 |
| Terazosin | 50 | $658 | $13 |
| Xopenex Hfa | 11 | $600 | $55 |
| Insulin | 24 | $555 | $23 |
| Enalapril Maleate | 51 | $552 | $11 |
| Albuterol Sulfate | 14 | $539 | $39 |
| Levothyroxine | 38 | $519 | $14 |
| Gabapentin | 23 | $506 | $22 |
| Lisinopril | 61 | $499 | $8 |
| Bupropion Hcl Sr | 12 | $485 | $40 |
| Promethazine | 21 | $448 | $21 |
| Omeprazole | 52 | $429 | $8 |
| Sertraline | 25 | $426 | $17 |
| Oxybutynin Chloride | 13 | $415 | $32 |
| Bd Ultra-Fine Pen Needle | 11 | $362 | $33 |
| Pravastatin | 11 | $361 | $33 |
| Amlodipine Besylate | 41 | $350 | $9 |
| Potassium Chloride | 19 | $349 | $18 |
| Trazodone | 40 | $332 | $8 |
| Finasteride | 13 | $324 | $25 |
| Divalproex | 12 | $323 | $27 |
| Glipizide | 21 | $252 | $12 |
| Lorazepam | 23 | $247 | $11 |
| Atenolol | 41 | $238 | $6 |
| Hydrochlorothiazide | 52 | $213 | $4 |
| Furosemide | 46 | $210 | $5 |
| Triamcinolone Acetonide | 15 | $208 | $14 |
| Paroxetine | 16 | $194 | $12 |
| Ranitidine | 22 | $191 | $9 |
| Ibuprofen | 25 | $185 | $7 |
| Metformin Hcl Er | 12 | $176 | $15 |
| Mirtazapine | 16 | $173 | $11 |
| Lovastatin | 17 | $172 | $10 |
| Metoprolol | 24 | $164 | $7 |
| Fluoxetine | 20 | $163 | $8 |
| Alprazolam | 13 | $161 | $12 |
| Zolpidem | 36 | $156 | $4 |
| Hydrocortisone | 25 | $153 | $6 |
| Diazepam | 31 | $149 | $5 |
| Lithium Carbonate | 12 | $113 | $9 |
| Dicyclomine | 13 | $106 | $8 |
| Meloxicam | 13 | $104 | $8 |
| Allopurinol | 12 | $100 | $8 |
| Carisoprodol | 13 | $100 | $8 |
| Benazepril | 11 | $98 | $9 |
| Prednisone | 12 | $87 | $7 |
| Clonazepam | 11 | $79 | $7 |
| Cyclobenzaprine | 15 | $70 | $5 |
Professional record
- NPI
- 1568515112
- Licence
- CA G77821California G77821: Current · expires 2027-07-31
- Trained
- University of California, San Francisco School of Medicine, 1992
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G778210
- Taxonomy
- Family medicine (207Q00000X); Federal specialty code 202D00000X (202D00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-01-18
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1110 N Dutton Ave, Santa Rosa, CA, 95401 · 34 Mark West Springs Rd Fl 2, Santa Rosa, CA, 95403 · 751 Lombardi Ct Ste B, Santa Rosa, CA, 95407